Inhibiting the VEGF/VEGFR pathway is an effective approach to treat cancer. It has also provided new insight into the physiological role of this pathway in various organs. Integrating the knowledge in daily oncological practice will be a challenge for the future.
No takes yet. Share an insight, caveat, or question.
Roodhart et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: